In fiscal year 2025, the company reported a loss of 232 million U.S. dollars. Elanco is an American pharmaceutical company producing pharmaceuticals for pets and livestock.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Elanco, & U.S. Securities and Exchange Commission. (February 24, 2026). Net income of Elanco Animal Health from 2015 to 2025 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 23, 2026, from /statistics/1149189/elanco-net-income/
Elanco, und U.S. Securities and Exchange Commission. "Net income of Elanco Animal Health from 2015 to 2025 (in million U.S. dollars)." Chart. February 24, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 23, 2026. /statistics/1149189/elanco-net-income/
Elanco, U.S. Securities and Exchange Commission. (2026). Net income of Elanco Animal Health from 2015 to 2025 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 23, 2026. /statistics/1149189/elanco-net-income/
Elanco, and U.S. Securities and Exchange Commission. "Net Income of Elanco Animal Health from 2015 to 2025 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 24 Feb 2026, /statistics/1149189/elanco-net-income/
Elanco & U.S. Securities and Exchange Commission, Net income of Elanco Animal Health from 2015 to 2025 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1149189/elanco-net-income/ (last visited July 23, 2026)
Net income of Elanco Animal Health from 2015 to 2025 (in million U.S. dollars) [Graph], Elanco, & U.S. Securities and Exchange Commission, February 24, 2026. [Online]. Available: /statistics/1149189/elanco-net-income/
